Premium
Therapeutics and COVID‐19—A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine
Author(s) -
Møller Morten H.,
Chew Michelle S.,
Olkkola Klaus T.,
Rehn Marius,
YliHankala Arvi,
Sigurðsson Martin I.
Publication year - 2022
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/aas.14046
Subject(s) - medicine , guideline , covid-19 , intensive care , trustworthiness , medline , family medicine , intensive care medicine , virology , outbreak , pathology , infectious disease (medical specialty) , computer security , disease , computer science , political science , law
The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID ‐ 19 . This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID‐19.